Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Top Ten Searches
post partum incontinence fibroid hpv colpotomy ovarian cyst curettage endometriosis intrauterine umbilical cordYour Article Summary
Anthracycline- and/or taxane-resistant breast cancer: Results of a literature review to determine the clinical challenges and current treatment trends
Clinical Therapeutics, 10/15/09
Moreno–Aspitia A et al. – Previous research has reported the efficacy of capecitabine, gemcitabine, nanoparticle albumin–bound paclitaxel, and ixabepilone in the treatment of metastatic BC in patients who have already been treated with anthracyclines and/or taxanes. Such patients previously had few treatment options. Ongoing investigations into novel combination regimens with these agents, including combinations with targeted agents, may further build on this progress. Further research is needed to understand the economic implications of these regimens, including the broader societal effects and the value to patients.
Related Articles
Systematic Review: Comparative Effectiveness of Medications to Reduce Risk for Primary Breast Cancer
Annals of Internal Medicine, 11/17/09
Relevance Score: 87%
The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study
Breast Cancer Research and Treatment, 11/12/09
Relevance Score: 87%
Expression and Significance of bag-1, bcl-2 in Non-small Cell Lung Cancer and the Correlation with Multi-drug Resistance
Chinese Journal of Lung Cancer, 10/21/09
Relevance Score: 87%
XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma
European Journal of Obstetrics & Gynecology and Reproductive Biology, 10/09/09
Relevance Score: 86%
Stress hormones mediate drug resistance to paclitaxel in human breast cancer cells through a CDK-1-dependent pathway
Psychoneuroendocrinology, 10/22/09
Relevance Score: 81%
Today in Breast...keeping you current
Receive free subspecialty "5-minute updates" via email
Worldwide first experiences with vacuum-assisted closure as alternative treatment method to repair defects of an extended thoracic wall recurrence of breast cancer
Archives of Gynecology and Obstetrics, 11/25/09
Excision of axillary lymph node recurrences in breast cancer patients with axillary ROLL
Journal of Surgical Oncology, 11/24/09
Urogenital Atrophy in Breast Cancer Survivors
Oncology Nursing Forum, 11/23/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
First-trimester use of paroxetine and congenital heart defects: A population-based case-control study
Birth Defects Research, 11/24/09
Suppression of follicular rupture with meloxicam, a cyclooxygenase-2 inhibitor: potential for emergency contraception
Human Reproduction, 11/24/09
The rationale for mTOR inhibition in epithelial ovarian cancer
Expert Opinion on Investigational Drugs, 11/24/09
Sponsor
Article Search
Sponsor


See Latest Articles


